Important update: Healthcare facilities
CDC has updated select ways to operate healthcare systems effectively in response to COVID-19 vaccination. Learn more
UPDATE
Given new evidence on the B.1.617.2 (Delta) variant, CDC has updated the guidance for fully vaccinated people. CDC recommends universal indoor masking for all teachers, staff, students, and visitors to K-12 schools, regardless of vaccination status. Children should return to full-time in-person learning in the fall with layered prevention strategies in place.
UPDATE
The White House announced that vaccines will be required for international travelers coming into the United States, with an effective date of November 8, 2021. For purposes of entry into the United States, vaccines accepted will include FDA approved or authorized and WHO Emergency Use Listing vaccines. More information is available here.
UPDATE
Travel requirements to enter the United States are changing, starting November 8, 2021. More information is available here.

Stay Up to Date with COVID-19 Vaccines Including Boosters

Stay Up to Date with COVID-19 Vaccines Including Boosters
Updated Mar. 2, 2023

What You Need to Know

Updated Boosters Are Recommended

CDC recommends 1 updated booster dose:

There is no booster recommendation for children aged 6 months–4 years who got the Pfizer-BioNTech COVID-19 vaccine primary series.

About COVID-19 Vaccines

COVID-19 vaccines available in the United States are effective at protecting people from getting seriously ill, being hospitalized, and dying. As with other vaccine-preventable diseases, you are protected best from COVID-19 when you stay up to date with the recommended vaccinations, including recommended boosters.

Four COVID-19 vaccines are approved or authorized in the United States:

  • Pfizer-BioNTech
  • Moderna
  • Novavax
  • Johnson & Johnson’s Janssen (J&J/Janssen) (CDC recommends that the J&J/Janssen COVID-19 vaccine only be considered in certain situations, due to safety concerns.)

To find COVID-19 vaccine locations near you: Search vaccines.gov, text your ZIP code to 438829, or call 1-800-232-0233.

COVID-19 Boosters

When Are You Up to Date?

You are up to date with your COVID-19 vaccines when you have completed a COVID-19 vaccine primary series and got the most recent booster dose recommended for you by CDC.

  • If you have completed your primary series—but are not yet eligible for a booster—you are also considered up to date.
  • If you become ill with COVID-19 after you received all COVID-19 vaccine doses recommended for you, you are also considered up to date. You do not need to be revaccinated or receive an additional booster.

COVID-19 vaccine recommendations are based on three things:

  1. Your age
  2. The vaccine you first received, and
  3. The length of time since your last dose

People who are moderately or severely immunocompromised have different recommendations for COVID-19 vaccines.

For Healthcare Workers: Learn more about COVID-19 vaccine schedules.

Getting Vaccines If You Had or Currently Have COVID-19

If you recently had COVID-19, you still need to stay up to date with your vaccines, but you may consider delaying your next vaccine dose (whether a primary dose or booster) by 3 months from:

  • when your symptoms started.
  • Or, if you had no symptoms, when you first received a positive test.

Reinfection is less likely in the weeks to months after infection. However, certain factors could be reasons to get a vaccine sooner rather than later, such as:

Children and teens aged 6 months–17 years

COVID-19 vaccine dosage is based on age on the day of vaccination, not on size or weight. Children get a smaller dose of COVID-19 vaccine than teens and adults.

Adults aged 18 years and older

Getting your 2nd dose: Talk to your healthcare or vaccine provider about the timing for the 2nd dose in your primary series.

  • People aged 6 months through 64 yearsand especially males aged 12 through 39 years, may consider getting the 2nd primary Pfizer-BioNTech, Moderna, or Novavax 8 weeks after the 1st dose.
    • A longer time between the 1st and 2nd primary doses may increase how much protection the vaccines offer, and further minimize the rare risk of myocarditis and pericarditis.
  • Anyone wanting protection due to high levels of community transmission, people aged 65 years and older, or people who are more likely to get very sick from COVID-19, should get the second dose of:
    • Pfizer-BioNTech COVID-19 vaccine 3 weeks (or 21 days) after the first dose.
    • Moderna COVID-19 vaccine 4 weeks (or 28 days) after the first dose.
    • Novavax COVID-19 vaccine 3 weeks (or 21 days) after the first dose.

Novavax booster: You may get a Novavax booster if you are unable or unwilling to receive a Pfizer or Moderna updated COVID-19 booster and you meet the following requirements:

  • You are 18 years of age or older
  • You completed a COVID-19 vaccine primary series at least 6 months ago
  • You have not gotten any other booster dose

One updated booster dose: If you have completed your updated booster dose, you are currently up to date. There is not a recommendation to get another updated booster dose.

Staying up to date: If you have completed your primary series, but are not yet eligible for a booster, you are also considered up to date.

Mixing COVID-19 Vaccine Products

Do Not Mix Primary Series

CDC does not recommend mixing products for your primary series doses. If you received Pfizer-BioNTech, Moderna, or Novavax for the first dose of your primary series, you should get the same product for all following primary series doses.

Mixing Boosters

The following information applies to people who want to get different products for their booster vaccine.

Learn About Getting Your Vaccine
  • Do you need to wait to get vaccinated after getting COVID-19 or getting treatment for COVID-19?
  • How can you prepare for vaccination?
  • What can you expect during and after your vaccination?
Getting Your COVID-19 Vaccine

Vaccination Received Outside the United States

Specific recommendations for people vaccinated outside the United States depend on whether:

  • The vaccine(s) received are accepted in the United States as valid vaccinations
  • The primary series was completed and, if eligible, a booster dose was received

These recommendations apply only to people who are not moderately or severely immunocompromised.